Controlling the Immune System with Small Molecule Drugs (1 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

Controlling the Immune System with Small Molecule Drugs (1 of 3)

Caption

An overview of potential applications of TLR1/2 agonists as vaccine adjuvant. This material relates to a paper that appeared in the April 10, 2015, issue of Science, published by AAAS. The paper, by K. Cheng at Tsinghua University in Beijing, China, and colleagues was titled, "Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists."

Credit

[Credit: Hang Hubert Yin and Kui Cheng]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.